Search by Blog
Read by Category

Your healing journey continues beyond this blog

Find the right products for better recovery at online store
Cart Image
Know the Stages of Lung Cancer
Know the Stages of Lung Cancer

Do you know that despite the advancements in the treatment options, lung cancer remains the leading cause of cancer deaths worldwide for men and the second leading cause for women?

In developed nations, lung cancer is the most common cause of cancer death among women (210,000 deaths) followed by breast cancer (198,000 deaths).

In our last blog, we discussed the 2 types of lung cancer, its complications, risk factors and how to reduce them.

In this blog, we have tried to cover the various stages of Non-small cell lung cancer (NSCLC), which contributes to 85% of the lung cancer types, the various diagnostic methods, and the available treatment options.

Stages of Lung Cancer:

The 2 different types of lung cancer spread in different stages. The different stages help to identify how far the tumor has spread and the treatment to be followed.

Following are the 4 different stages of non-squamous cell lung cancer:

STAGE 1: Cancer is confined to the lungs only and has not yet spread.
STAGE 2: The cancer spreads to the nearby lymph nodes.
STAGE 3: The tumorous cells are found in the lungs, lymph nodes in the middle of the chest. This stage may further be sub-divided into 2 stages based on the side where cancer spreads.
In Stage 3A, The cancer spreads to the lymph nodes which are on the same side of the chest where cancer originated while in Stage 3B, cancer spreads to the opposite side or to the lymph nodes above the collarbone.
STAGE 4: Cancer cells spread to both the lungs or to the surrounding area or to the distant organs.

SCLC Spreads in 2 main stages. In the “limited stage”, cancer is confined to one side of the chest, including one part of the lung and nearby lymph nodes. In the “extensive stage”, cancer cells spread to other parts of the body and the chest.

Diagnosis:
Diagnosis plays an important role, as patient outcomes can improve if the disease is diagnosed at an early stage. However, it is difficult to identify lung cancer at early stages because its symptoms may overlap with those of respiratory infection.

After a physical examination, the doctor may recommend the following diagnostic tests:
– IMAGING TESTS which help to identify any abnormal growth of cells. These may include X-ray, MRI, CT, and PET scans.
– SPUTUM CYTOLOGY, a microscopic examination can help to determine the presence of cancer cells. This may be done if you produce phlegm on coughing.
– BIOPSY may be done to determine if the abnormal growth is cancerous. If the pathological analysis comes positive, further testing such as a bone scan can be done to identify if cancer has spread or not and its stage.

Treatment:
The various treatment options available for lung cancer include surgery, radiation therapy, chemotherapy, radiosurgery, immunotherapy, targeted drug therapy, and palliative care.

SURGICAL METHODS include removing lung cancer and a margin of healthy tissue. Surgery is an option you need for stage 1 NSCLC.

Chemotherapy is often used post surgery to destroy any remaining cancer cells or in patients who are at a high risk of recurrence. Its usually recommended for stage 2 NSCLC and in combination with surgery and radiation therapy in stage 3 NSCLC.

– It is difficult to control stage 4 NSCLC as the cancer cells have spread enough. Treatment may include surgery, radiation, chemotherapy, targeted therapy, and immunotherapy or a combination of these.

– In more advanced stages, where some patients choose not to continue the treatment, palliative care may still help to relieve the cancer symptoms rather than treating cancer itself.

We @DattMediproducts understand that there are no obvious symptoms of the disease at early stages and the diagnosis comes into picture only once cancer has spread.

However, there are ways in which we can reduce the risk. You can follow our previous blog to know more about the complications, risks and how to reduce them.

Visit www.dattmedi.com for more infomation.
Share:
Recent Blogs

In the realm of wound care, continuous advancements are constantly improving the way we treat and manage various types of wounds. Among the latest innovations, Velseal® -T Disc has emerged as a game-changer. This revolutionary product offers an effective and convenient solution for promoting wound healing and enhancing patient comfort.

Understanding Velseal® -T Disc

It is a cutting-edge wound care product designed to optimize the healing process while minimizing discomfort for patients. Velseal® -T Disc promotes haemostasis by absorbing the blood and accumulates clotting factor within the voids and initiate the clotting by interaction with Thrombin, Calcium chloride and Tranexamic acid.

Key Features and Benefits:

1. Advanced Composition:

It is composed of high-quality materials that offer excellent absorption and retention capacities, reducing the risk of maceration and infection. However, it does not provide moisture balance or directly contribute to wound healing.

2. Easy Application:

Thee disc-shaped design of Velseal® -T Disc allows for simple and hassle-free application. Its non-adherent nature eliminates the need for additional fixation methods, providing a secure and comfortable fit. The dressing is available in various sizes to accommodate different wound types and locations.

3. Enhanced Patient Comfort:

It prioritizes patient comfort by minimizing pain and trauma during dressing changes. The non-adherent surface prevents the dressing from sticking to the wound bed, reducing discomfort and potential damage to healing tissue.

4. Cost-Effective Solution:

It offers a cost-effective wound care solution, as it requires no dressing changes. A single application helps in achieving complete hemostasis, contributing to overall healthcare cost savings. Its durability and prolonged wear time further enhance its cost-effectiveness.

Clinical Efficacy and Evidence

The product has undergone rigorous testing and evaluation to validate its clinical efficacy. Clinical studies have demonstrated its effectiveness in promoting faster wound healing, reducing pain, and minimizing complications such as infection. These studies highlight the dressing’s superior moisture management capabilities and its ability to facilitate granulation tissue formation, resulting in improved patient outcomes.

In the rapidly evolving field of wound care, the Velseal® -T Disc stands out as a remarkable innovation. Its unique composition, easy application, and patient-centric design make it a valuable addition to any healthcare setting. With its demonstrated clinical efficacy and cost-effectiveness, this advanced dressing offers a promising solution for healthcare professionals and patients alike. By leveraging the benefits of Velseal® -T Disc, healthcare providers can enhance wound healing outcomes and improve the overall quality of care for patients with acute or chronic wounds.

In our fast-paced and demanding modern world, it has become increasingly crucial to prioritize our health and well-being. Among the myriad of health concerns affecting millions worldwide, cancer stands as one of the most significant challenges we face. However, with advances in medical science, early detection has emerged as a powerful tool in the fight against this devastating disease. In this blog, we will explore the importance of early cancer detection, shed light on screening guidelines, and emphasize the necessity of regular screenings for various types of cancer.

The Impact of Early Cancer Detection: Early detection plays a pivotal role in improving cancer outcomes and significantly increasing the chances of successful treatment. When cancer is detected in its early stages, before it has metastasized, treatment options are often less aggressive and more effective. Moreover, early detection significantly enhances survival rates, underscoring the vital importance of regular screenings for individuals.

Screening Guidelines for Different Types of Cancer:

Breast Cancer:

Among women, breast cancer is one of the most prevalent forms of the disease. The American Cancer Society advises that women aged 40 and above should undergo annual mammograms for breast cancer screening. However, individual risk factors may warrant earlier screenings or additional tests.


Colorectal Cancer:

Affecting both men and women, colorectal cancer ranks as the third most common cancer globally. Screening for colorectal cancer typically begins at the age of 45. Methods such as colonoscopy, sigmoidoscopy, and stool-based tests are employed to detect abnormal growths or cancerous cells in the colon or rectum.

Cervical Cancer:

Regular screenings and human papillomavirus (HPV) vaccination can prevent cervical cancer. The American Cancer Society recommends cervical cancer screening for individuals with a cervix starting at the age of 25. This can be achieved through a Pap test, an HPV test, or a combination of both.

Lung Cancer:

As the leading cause of cancer-related deaths worldwide, lung cancer poses a significant threat. For individuals at high risk, such as current or former smokers, low-dose computed tomography (LDCT) scans are recommended. Screening should commence at the age of 50 and continue until age 80, or as long as the individual is in good health.


Prostate Cancer:

Primarily affecting men, prostate cancer typically develops in older individuals. The American Cancer Society advises men to discuss the potential benefits and risks of prostate cancer screening with their healthcare provider. Screening options include prostate-specific antigen (PSA) blood tests and digital rectal exams.

Early cancer detection can save lives by enabling more effective treatment options and improving survival rates. By adhering to the recommended screening guidelines for different types of cancer, individuals can take proactive steps towards their health and potentially detect cancer in its early stages.

Through raising awareness, educating the public, and advocating for regular screenings, we can work together to alleviate the burden of cancer and enhance overall healthcare outcomes. Remember, prevention and early detection are the keys to triumphing over cancer. This strategic stance promises extended lives, improved outcomes, and a brighter future for all, underscoring the vital role of early cancer detection as a beacon of hope in a world where health is paramount.

×